Point of Care Blog

In Part 1, we discussed the focused information clinicians need to quickly assess an anticoagulation patient’s health and a review of patient treatment plan trends.  Here in part 2, we will discuss the many ways to identify patients who are at risk for drug interactions or re-admissions, and evidence-based guidelines that support dosing decisions.

 Identify Patients at Risk

There are many ways to identify patients that require a bit of extra scrutiny.  PCDS believes it is important that a clinician is immediately made aware of any patients with higher than normal levels of risk given their care plan.  We further believe it is important that risk identifiers be objective and measurable.  That is why AC has three validated survey instruments built into the application for easy access, execution as well as to clearly demonstrate the results of completed surveys when they indicate patients may be at risk.

Part 1 of a 2 part series

Evolving how clinicians interact with patients is a top priority in the Healthcare industry today. At Point of Care Decision Support (PCDS), we understand the importance of delivering solutions that facilitate strong communication between patients and caregivers. 

 We are working with technology and medical professionals to connect clinicians at the point of care with actionable information to promote patient engagement, medication dosing best practices (for volatile medications such as warfarin), and measuring outcomes that are vital to patient safety and improved treatment plans across diverse health systems. 

 When I accepted the opportunity to join Point of Care Decision Support (PCDS) last year, people were curious. Considering everything going on in healthcare today, why PCDS?

I could have reflected on all the positive reasons why it made so much sense:

• The entrepreneurial spirit of the company.
• The solid technology base of the solution.
• The tremendous growth happening in the healthcare marketplace.